KRAS variants in human pancreatic cancer: new key findings
Researchers have identified underlying KRAS mutations which drive associated risk of particular clinical outcomes.
List view / Grid view
Researchers have identified underlying KRAS mutations which drive associated risk of particular clinical outcomes.
Genome and transcriptome sequencing revealed that subtypes such as TCF3/4::HLF were associated with an increased risk of relapse.
The study’s results indicate that spatial sequencing of mixed-type breast cancers could inform personalised treatment.
Understanding how MMR-deficient colorectal cancers drive tumour growth and avoid immune detection could pave the way for personalised cancer medicine.
The discovery that omental fat has a mechanism to limit adipocyte formation may lead to new treatments for obesity and metabolic disease.
Researchers have developed a new tool called ‘Uveal Melanoma Immunogenic Score’ to predict which patients will respond to adoptive therapy.
Researchers have identified that gestational diabetes is associated with a deficit in placental expression of IGFBP1.
Single-cell RNA sequencing of ovaries resulted in the identification of four major cell types and four immune cell subtypes.
Researchers have gained a deeper understanding of the neural biology of obesity, which could offer potential drug targets.
Learn more about Euretos computational disease model and how it predicts many of the known drug targets for RA.
Understanding the mechanisms in lung formation could develop new therapeutic approaches for respiratory conditions.
Researchers have completely decoded the human Y chromosome, which may result in more effective treatment for digestive disorders.
This ebook outlines Euretos’ approach to target discovery and indication expansion. Whilst also discussing data-driven target selection.
25 July 2023 | By CN Bio
The webinar will explore primary concerns in drug discovery development and why drugs fail.
Swedish study reveals a significant link between specific gut bacteria and the development of coronary atherosclerotic plaques, a leading cause of heart attacks.